값202020212022202320242025TTM판매비·일반관리비———————연구개발———————영업 이익———————비영업 수익, 합계———————이자비용(자본화한 이자 차감 후)———————이자비용을 제외한 비영업 수익———————비정상 수입/지출———————세전소득———————지분법 손익———————세금———————비지배 지분———————세후 기타 수익/비용———————중단된 사업 부문 제외 순이익———————중단된 사업———————순이익———————희석보정———————우선배당———————보통주주에게 귀속되는 희석 순이익———————주당 순이익(기본 EPS)———————희석 주당 순이익 (희석 EPS)———————평균 발행주식수———————희석주식수———————EBITDA———————EBIT———————매출원가———————기타 매출원가———————감가상각 및 무형자산 상각 (현금흐름)———————
Sanofi - American Depositary Shares
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur.